Nalmefene--a long-acting injectable opioid antagonist.
D002986:Clinical Trials as Topic; D003365:Costs and Cost Analysis; D004305:Dose-Response Relationship, Drug; D062787:Drug Overdose / Q000188:drug therapy; D006801:Humans; D007275:Injections, Intravenous; D007676:Kidney Failure, Chronic; D008107:Liver Diseases / Q000503:physiopathology; D009271:Naltrexone / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000494:pharmacology; D009292:Narcotic Antagonists / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology*; D011182:Postoperative Care / Q000191:economics; D012131:Respiratory Insufficiency / Q000188:drug therapy
D009292:Narcotic Antagonists; D009271:Naltrexone; C038981:nalmefene